Methylnaltrexone
Methylnaltrexone is a pharmaceutical drug with 19 clinical trials. Currently 1 active trials ongoing. Historical success rate of 81.3%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
2
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
72.2%
13 of 18 finished
27.8%
5 ended early
1
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids
Subcutaneous Methylnaltrexone Versus Placebo for Postoperative Ileus Prevention
Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation
Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects
Clinical Trials (19)
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids
Subcutaneous Methylnaltrexone Versus Placebo for Postoperative Ileus Prevention
Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation
Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects
Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide
Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX
A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain
Compassionate Use Study of Methylnaltrexone
Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)
Methylnaltrexone for Opioid Induced Constipation
Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness
Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine
Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients
Methylnaltrexone Use for Opioid-induced Postoperative Constipation
Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates
Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.
Opioids and Esophageal Function
Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients
All 19 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 19